γ-Synuclein Promotes Cancer Cell Survival and Inhibits Stress- and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways
Authors:
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (38) , 35050-35060
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- α-Synuclein Affects the MAPK Pathway and Accelerates Cell DeathJournal of Biological Chemistry, 2001
- Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequencesOncogene, 2001
- Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insultJournal of Neurochemistry, 2001
- Induction of neuronal death by α‐synucleinEuropean Journal of Neuroscience, 2000
- Differential Involvement of MEK Kinase 1 (MEKK1) in the Induction of Apoptosis in Response to Microtubule-targeted Drugsversus DNA Damaging AgentsJournal of Biological Chemistry, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosisEuropean Journal of Cancer, 1995